Increased 24-hour urinary cortisol excretion in patients with post- traumatic stress disorder and patients with major depression, but not in patients with fibromyalgia

Acta Psychiatrica Scandinavica

Volumn 98, Issue 4, 1998, Pages 328-335

  Maes, M ^a,b   Lin, A ^a   Bonaccorso, S ^a,c   Van Hunsel, F ^a   Van Gastel, A ^a   Delmeire, L ^a   Biondi, M ^c   Bosmans, E ^d   Kenis, G ^d   Scharpe S ^e  

^a Clinical Research Center for Mental Health of Antwerp   (Belgium)

^b VANDERBILT UNIVERSITY   (United States)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d Eurogenetics   (Belgium)

^e UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Fibromyalgia; Major depression; Post traumatic stress disorder; Urinary cortisol

Indexed keywords

HYDROCORTISONE;

ARTICLE; CONTROLLED STUDY; DEPRESSION; FEMALE; FIBROMYALGIA; HUMAN; HYDROCORTISONE RELEASE; HYDROCORTISONE URINE LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MAJOR CLINICAL STUDY; MALE; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL;

EID: 15144347314     PISSN: 0001690X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0447.1998.tb10092.x     Document Type: Article

References (44)

1. MAES M, VANDERVORST C, SUY E, MINNER B, RAUS J. A multivariate study on the simultaneous urinary free cortisol, plasma cortisol, adrenocorticotropic hormone and β-endorphin escape from suppression by dexamethasone in melancholic patients. Acta Psychiatr Scand 1991: 83: 480-491.
2. RUNDELL JR, URSANI, RJ, SILBERMAN EK. Post-traumatic stress disorder's relationship of depressive illness. Am J Psychiatry 1986: 143: 267-268.
3. MASON JW, GILLER EL, KOSTEN TR, OSTROFF RB, PODD L. Urinary free-cortisol levels in post-traumatic stress disorder patients. J Nerv Ment Dis 1986: 174: 145-159.
4. YEHUDA R, LEVENGOOD RA, SCHMEIDLER J, WILSON S, GUO LS, GERBER D. Increased pituitary activation following metyrapone administration in post-traumatic stress disorder. Psychoneuroendocrinology 1996: 21: 1-16.
5. DE BELLIS MD, CHROUSOS GP, DORN LD et al. Hypothalamic-pituitary-adrenal axis dysregulation in sexually abused girls. J Clin Endocrinol Metab 1993: 78: 249-255.
6. PITMAN R, ORR S. Twenty-four-hour urinary cortisol and catecholamine excretion in combat-related post-traumatic stress disorder. Biol Psychiatry 1990: 27: 245-247.
7. LEMIEUX AM, COE CL. Abuse-related post-traumatic stress disorder: evidence for chronic neuroendocrine activation in women. Psychosom Med 1995: 57: 105-115.
8. WOLFE F, SMYTHE HA, YUNUS MB et al. The American College of Rheumatology 1990: Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheumatol 1990: 33: 160-172.
9. HERNANZ W, VALENZUELA A, QUIJADA J et al. Lymphocyte subpopulations in patients with primary fibromyalgia. J Rheumatol 1994: 21: 2122-2124.
10. KRAG NJ, NORREGAARD J, LARSEN JK, DANNESKIOLD-SAMSOE B. A blinded controlled evaluation of anxiety and depressive symptoms in patients with fibromyalgia, as measured by standardized psychometric interview scales. Acta Psychiatr Scand 1994: 89: 370-375.
11. HUDSON JI, HUDSON MS, PLINER LF, GOLDBENBERG DL, POPE HG JR. Fibromyalgia and major affective disorder: a controlled phenomenology and family history study. Am J Psychiatry 1985: 142: 441-446.
12. MCCAIN GA, TILBE KS. Diurnal variation in fibromyalgia syndrome: a comparison with rheumatoid arthritis. J Rheumatol 1989: 19 (Suppl.): 154-157.
13. CROFFOLD LJ, PILLEMER SR, KALOGERAS KT et al. Hypothalamic-pituitary-adrenal axis perturbations in patients with fibromyalgia. Arthritis Rheumatol 1994: 37: 1583-1592.
14. VAN DENDEREN JC, BOERSMA JW, ZEINSTRA P, HOLLANDER AP, VAN NEERBOS BR. Physiological effects of exhaustive physical exercise in primary fibromyalgia syndrome (PFS): is PFS a disorder of neuroendocrine reactivity? Scand J Rheumatol 1992: 21: 35-37.
15. HUDSON JI, PLINER LF, HUDSON MS et al. The dexamethasone suppression test in fibrositis. Biol Psychiatry 1984: 19: 1489-1493.
16. DISDIER P, HARLE J-R, BRUE T et al. Severe fibromyalgia after hypophysectomy for Cushing's disease. Arthritis Rheumatol 1991: 34: 493-495.
17. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, revised 3rd edn. Washington, DC: American Psychiatric Association, 1987.
18. RAVINDRAN AV, GRIFFITHS J, WADDELL C, ANISMAN H. Stressful life events and coping styles in relation to dysthymia and major depressive disorder: variations associated with alleviation of symptoms following pharmacotherapy. Prog Neuropsychopharmacol Biol Psychiatry 1995: 19: 637-653.
19. WILKE WS. Fibromyalgia. Recognizing and addressing the multiple interrelated factors. Postgrad Med J 1996: 100: 153-156.
20. GRUBER AJ, HUDSON JI, POPE HG. The management of treatment-resistant depression in disorders on the interface of psychiatry and medicine. Fibromyalgia, chronic fatigue syndrome, migraine, irritable bowel syndrome, atypical facial pain, and premenstrual dysphoric disorder. Psychiatr Clin North Am 1996: 19: 351-369.
21. VAN DER KOLK BA, DREYFUSS D, MICHAELS M et al. Fluoxetine in post-traumatic stress disorder. J Clin Psychiatry 1994: 55: 517-522.
22. PEIFFER A, VEILLEUX S, BARDEN N. Antidepressant and other centrally acting drugs regulate glucocorticoid receptor messenger RNA levels in rat brain. Psychoneuroendocrinology 1991: 16: 505-515.
23. SPITZER RL, WILLIAMS JBW, GIBBON MSW, FIRST MB. Structured Clinical Interview according to DSM-III-R. Washington, DC: American Psychiatric Press, 1990.
24. JANCA A, ÜSTU}DN TB, SARTORIUS N. New versions of World Health Organization instruments for the assessment of mental disorders. Acta Psychiatr Scand 1994: 90: 73-83.
25. PETERS L, ANDREWS G, COTTLER LB, CHATTER S, JANCA A, SMEETS RMW. The Composite International Diagnostic Interview Post-Traumatic Stress Disorder Module: preliminary data. Int J Meth Psychiatr Res 1996: 6: 167-174.
26. TIETZ NW. Clinical guide to laboratory tests, 2nd edn. Philadelphia, PA: WB Saunders Company, 1990.
27. HAMILTON M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960: 23: 56-61.
28. HOWELL DC. Multiple comparisons among treatment means. In: HOWELL DC, ed. Statistical methods for psychology. Boston, MA: Duxbury Press, 1982: 289-307.
29. ZWEIG MH, CAMPBELL G. Receiver operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 1993: 39: 561-577.
30. YEHUDA R, KAHANA B, BINDER-BRYNES K, SOUTHWICK SM, MASON JW, GILLER EL. Low urinary cortisol excretion in holocaust survivors with post-traumatic stress disorder. Am J Psychiatry 1995: 152: 982-986.
31. KUDLER H, DAVIDSON J, MEADOR K, LIPPER S, ELY T. The DST and post-traumatic stress disorder. Am J Psychiatry 1987: 144: 1068-1071.
32. OLIVERA AA, FERO D. Affective disorders. DST, and treatment in PTSD patients: clinical observations. J Traumatic Stress 1990: 3: 407-414.
33. HALBREICH U, OLYMPIA J, CARSON S et al. Hypothalamo-pituitary-adrenal activity in endogenously depressed post-traumatic stress disorder patients. Psychoneuroendocrinology 1989: 14: 365-370.
34. KOSTEN TR, WAHBY V, GILLER E JR, MASON J. The dexamethasone suppression lest and thyrotropin-releasing hormone stimulation test in post-traumatic stress disorder. Biol Psychiatry 1990: 28: 657-664.
35. DARNELL A, BREMNER JD, LICINIO J et al. CSF levels of corticotropin-releasing factor in chronic post-traumatic stress disorder. Neurosci Abstr 1994: 20: 15A.
36. SMITH MA, DAVIDSON J, RITCHIE JC et al. The corticotropin-releasing hormone test in patients with post-traumatic stress disorder. Biol Psychiatry 1989: 26: 349-355.
37. MAES M, CLAES M, VANDERWOUDE M et al. Adreno-corticotropin hormone, β-endorphin and cortisol responses to oCRH in melancholic patients. Psychol Med 1992: 22: 317-329.
38. MAES M, MELTZER HY, COSYNS P, CALABRESE J, D'HONDT P, BLOCKX P. Adrenocorticotropic hormone, β-endorphin and cortisol responses to oCRH in unipolar depressed patients pretreated with dexamethasone: a further exploration of the pathophysiology underpinning HPA-axis dysfunction in melancholia. Prog Neuropsychopharmacol Biol Psychiatry 1994: 18: 1273-1292.
39. CLEARE AJ, BEARN J, ALLAIN T et al. Contrasting neuroendocrine responses in depression and chronic fatigue syndrome. J Affect Disord 1995: 18: 283-289.
40. MAES M, BOSMANS E, MELTZER HY, SCHARPÉ S, SUY E. Interleukin-1β: a putative mediator of HPA-axis hyperactivity in major depression? Am J Psychiatry 1993: 150: 1189-1193.
41. SPIVAK B, SHOHAT B, MESTER R et al. Elevated levels of serum interleukin-1 in combat-related post-traumatic stress disorder. Biol Psychiatry 1997: 42: 345-348.
42. MAES M, MINNER B, SUY E, VANDERVORST C, RAUS J. Coexisting dysregulations of both the sympathoadrenal system and hypothalamic-pituitary-adrenal axis in melancholia. J Neural Transm 1991: 85: 195-210.
43. KOSTEN TR, MASON JW, GILLER EL, OSTROFF RB, HARKNESS L. Sustained urinary norepinephrine and epinephrine elevation in post-traumatic stress disorder. Psychoneuroendocrinology 1987: 12: 13-20.
44. ELAM M, JOUANSSON G, WALLIN BG. Do patients with primary fibromyalgia have an altered muscle sympathetic nerve activity? Pain 1992: 48: 371-375.